These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33460665)

  • 41. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Chen B; Liu S; Gan L; Wang J; Hu B; Xu H; Tong R; Yang H; Cristina I; Xue J; Hu X; Lu Y
    Cancer Biol Ther; 2018 Jan; 19(1):76-86. PubMed ID: 29257923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ACP-5862 suppresses esophageal squamous cell carcinoma growth through inducing apoptosis via activation of endoplasmic reticulum stress and ROS production.
    Liu Q; He J; Zhou X; Han M; Li J; Liu C; Yuan H
    Biochem Biophys Res Commun; 2021 Jan; 534():995-1002. PubMed ID: 33168189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage.
    Ye J; Ma J; Liu C; Huang J; Wang L; Zhong X
    Biochem Pharmacol; 2019 Aug; 166():93-107. PubMed ID: 31078603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
    BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.
    Chen L; Bi S; Wei Q; Zhao Z; Wang C; Xie S
    J Cell Mol Med; 2020 May; 24(9):5387-5401. PubMed ID: 32237037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
    Liu X; Yan Y; Ma W; Wu S
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miRNA-574-5p downregulates ZNF70 and influences the progression of human esophageal squamous cell carcinoma through reactive oxygen species generation and MAPK pathway activation.
    Han GL; Wang J; Guo K; Chen JK; Shang RX; Jiang T
    Anticancer Drugs; 2020 Mar; 31(3):282-291. PubMed ID: 32053575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
    Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
    Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
    Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S
    Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trichostatin A augments esophageal squamous cell carcinoma cells migration by inducing acetylation of RelA at K310 leading epithelia-mesenchymal transition.
    Huang K; Liu Y; Gu C; Liu D; Zhao B
    Anticancer Drugs; 2020 Jul; 31(6):567-574. PubMed ID: 32282366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Hu antigen R/interferon-β axis modulates sensitivity of esophageal squamous cancer cells to cisplatin.
    Cui YY; Zhu XF; Zhang S
    Neoplasma; 2022 Mar; 69(2):383-391. PubMed ID: 35225647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aurora kinase inhibitor VX-680 enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy.
    Kou J; Wang X; Wei Y; Zhao R; Wang X; He J; Li X; Wang X
    Anticancer Drugs; 2021 Oct; 32(9):969-977. PubMed ID: 34016831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. G2 and S phase-expressed-1 induces chromosomal instability in esophageal squamous cell carcinoma cells and inhibits cell apoptosis through ROS/JNK signaling.
    Zhang M; Wang X; Liu C; Zheng Z; Wan J; Yang Y; Chen S; Liu H
    Mol Carcinog; 2023 Feb; 62(2):122-134. PubMed ID: 36193884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.
    Sun Y; Zhai L; Ma S; Zhang C; Zhao L; Li N; Xu Y; Zhang T; Guo Z; Zhang H; Xu P; Zhao X
    Cancer Lett; 2018 Apr; 418():97-108. PubMed ID: 29331417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.
    Yang K; Xie Y; Xue L; Li F; Luo C; Liang W; Zhang H; Li Y; Ren Y; Zhao M; Wang W; Liu J; Shen X; Zhou W; Fei J; Chen W; Gu W; Wang L; Li F; Hu J
    J Transl Med; 2023 Jan; 21(1):26. PubMed ID: 36641471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process.
    Ke Y; Guo W; Huang S; Li Y; Guo Y; Liu X; Jin Y; Ma H
    Life Sci; 2020 Jun; 250():117578. PubMed ID: 32209426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.
    Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G
    Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.